Hi, wounded, what I meant was ultimate winners or losers. I've had many a biotech loser that I could have easily broken even on by selling into anticipation of trial results, for example. They ended up being losers, but I didn't have to lose on it, in fact, you can often be a winner with a developmental company that ultimately fails. We are usually given opportunities with developmental stage companies, as investors tend to love them.

Frankly, I think I can talk a decent game, but, alas, I fall prey to emotions like most. There are some very successful stock players that have the discipline to take advantage of the many emotional players.